Research To Practice | Oncology Videos

Latest Episodes:

EGFR Mutation-Positive Non-Small Cell Lung Cancer — Proceedings from a Session Held During the 2025 ASCO Annual Meeting Jun 20, 2025

Show notes

Featuring perspectives from Prof Nicolas Girard, Dr Jonathan Goldman, Dr Pasi A Jänne, Dr Suresh S Ramalingam, Dr Joshua K Sabari and Dr Helena Yu, moderated by Dr Yu, including the following topics:

Introduction (0:00)
Evolving First-Line Treatment for Metastatic EGFR Mutation-Positive Non-Small Cell Lung Cancer (NSCLC) — Dr Yu (1:47)
EGFR-Targeted Approaches for Relapsed EGFR-Mutant NSCLC; Strategies to Facilitate Delivery of Recently Approved Agents — Dr Sabari (23:48)
Potential Utility of TROP2-Targeted Therapy in the Management of EGFR-Mutant NSCLC — Dr Ramalingam (45:16)
Contemporary Care for Patients with Nonmetastatic EGFR-Mutant NSCLC — Dr Goldman (1:03:56)
Current and Future Management of EGFR Exon 20 Mutation-Positive NSCLC — Prof Girard (1:24:40)
Emerging Role of HER3-Targeted Therapy in the Management of EGFR-Mutant NSCLC — Dr Jänne (1:43:46)

CME information and select publications

Advanced Gastroesophageal Cancers — Expert Perspectives on Actual Patient Cases: Part 1 of 2 Jun 19, 2025

Show notes

Featuring perspectives from Dr Geoffrey Y Ku and Dr Zev Wainberg, including the following topics:

Introduction: ASCO Preview (0:00)
HER2-Positive Gastroesophageal Cancers (19:03)
Immunotherapy in HER2-Negative Advanced Gastroesophageal Cancers (36:11)
Immunotherapy in Microsatellite Instability-High Gastroesophageal Cancers (44:04)
CLDN18.2-Positive Advanced Gastroesophageal Cancers (51:30)

CME information and select publications

Multiple Myeloma — Year in Review Series on Relevant New Datasets and Advances Jun 18, 2025

Show notes

Featuring perspectives from Prof Meletios-Athanasios (Thanos) C Dimopoulos and Dr Robert Z Orlowski, including the following topics:

Introduction: ASCO 2025 Preview (0:00)
Anti-CD38 Antibodies (10:12)
Belantamab Mafodotin (29:45)
CAR T-Cell Therapy (40:57)
Bispecific Antibodies (47:33)
Other Novel Agents (56:46)

CME information and select publications

Multiple Myeloma | Meletios-Athanasios (Thanos) C Dimopoulos, MD Jun 17, 2025

Show notes

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Multiple Myeloma | Faculty Presentation 2: Chimeric Antigen Receptor (CAR) T-Cell Therapy, Bispecific Antibodies and Antibody-Drug Conjugates (ADCs) — Meletios-Athanasios (Thanos) C Dimopoulos, MD

CME information and select publications

Multiple Myeloma | Robert Z Orlowski, MD, PhD Jun 17, 2025

Show notes

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Multiple Myeloma | Faculty Presentation 1: Current and Emerging Therapeutic Approaches for Multiple Myeloma (MM) — Robert Z Orlowski, MD, PhD

CME information and select publications

For Oncology Nurses: Hormone Receptor-Positive Breast Cancer — Proceedings from the 2025 Annual ONS Congress Jun 16, 2025

Show notes

Featuring perspectives from Dr Virginia F Borges, Ms Jamie Carroll, Mr Ronald Stein and Dr Seth Wander, including the following topics:

Introduction (0:00)
Role of CDK4/6 Inhibitors in Localized and Metastatic Hormone Receptor (HR)-Positive Breast Cancer (12:49)
PI3K Inhibition as First-Line Treatment for HR-Positive, HER2-Negative Metastatic Breast Cancer (mBC) (38:24)
Clinical Utility of AKT and PI3K Inhibitors in Progressive HR-Positive mBC (1:01:44)
Current and Future Role of Oral Selective Estrogen Receptor Degraders in HR-Positive mBC (1:24:38)

NCPD information and select publications

Myelofibrosis — Year in Review Series on Relevant New Datasets and Advances Jun 13, 2025

Show notes

Featuring perspectives from Prof Claire Harrison and Dr John Mascarenhas, including the following topics:

Introduction (0:00)

New Biology of Myelofibrosis (1:55)
Novel Regulatory T-Cell Infusion Therapy (14:57)
Myelofibrosis 2025: JAK Inhibitors (Ruxolitinib) (20:39)
BET Inhibitors: Pelabresib (42:03)
Navtemadlin (53:20)

CME information and select publications

Myelofibrosis | John Mascarenhas, MD Jun 12, 2025

Show notes

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Myelofibrosis | Faculty Presentation 2: Novel Investigational Strategies — John Mascarenhas, MD

CME information and select publications

Myelofibrosis | Professor Claire Harrison Jun 12, 2025

Show notes

Year in Review: Clinical Investigator Perspectives on the Most Relevant New Datasets and Advances in Myelofibrosis | Faculty Presentation 1: Current Management of Myelofibrosis (MF) — Professor Claire Harrison

CME information and select publications

For Oncology Nurses: Gastroesophageal Cancer — Proceedings from the 2025 Annual ONS Congress Jun 11, 2025

Show notes

Featuring perspectives from Dr Sunnie Kim, Ms Brooke Parker, Ms Michal Segal and Dr Manish Shah, including the following topics:

Introduction: Clinical Presentation of Gastroesophageal Cancer (0:00)
Management of Localized or Locally Advanced Gastroesophageal Cancers; Current and Future Role of Immune Checkpoint Inhibitors (21:44)
Incorporation of Immunotherapeutic Strategies for HER2-Negative Metastatic Gastroesophageal Tumors (39:32)
Role of Therapy Targeting CLDN18.2 in Advanced Gastric/Gastroesophageal Junction Adenocarcinoma (1:00:50)
Considerations in the Care of Patients with HER2-Positive Gastroesophageal Cancers (1:22:41)

NCPD information and select publications